485 related articles for article (PubMed ID: 22984603)
1. Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.
Mewes A; Franke H; Singer D
PLoS One; 2012; 7(9):e45017. PubMed ID: 22984603
[TBL] [Abstract][Full Text] [Related]
2. Astrocytes in mouse models of tauopathies acquire early deficits and lose neurosupportive functions.
Sidoryk-Wegrzynowicz M; Gerber YN; Ries M; Sastre M; Tolkovsky AM; Spillantini MG
Acta Neuropathol Commun; 2017 Nov; 5(1):89. PubMed ID: 29187256
[TBL] [Abstract][Full Text] [Related]
3. Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice cultures.
Schweig JE; Yao H; Jin C; Crawford F; Mullan M; Paris D
Neurosci Lett; 2020 Jun; 729():134992. PubMed ID: 32334108
[TBL] [Abstract][Full Text] [Related]
4. A Combination of Heavy Metals and Intracellular Pathway Modulators Induces Alzheimer Disease-like Pathologies in Organotypic Brain Slices.
Korde DS; Humpel C
Biomolecules; 2024 Jan; 14(2):. PubMed ID: 38397402
[TBL] [Abstract][Full Text] [Related]
5. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
6. Organotypic Hippocampal Slice Cultures from Adult Tauopathy Mice and Theragnostic Evaluation of Nanomaterial Phospho-TAU Antibody-Conjugates.
Kemppainen S; Huber N; Willman RM; Zamora A; Mäkinen P; Martiskainen H; Takalo M; Haapasalo A; Sobrino T; González Gómez MA; Piñeiro Y; Rivas J; Himmelreich U; Hiltunen M
Cells; 2023 May; 12(10):. PubMed ID: 37408256
[TBL] [Abstract][Full Text] [Related]
7. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
9. PSAPP mice exhibit regionally selective reductions in gliosis and plaque deposition in response to S100B ablation.
Roltsch E; Holcomb L; Young KA; Marks A; Zimmer DB
J Neuroinflammation; 2010 Nov; 7():78. PubMed ID: 21080947
[TBL] [Abstract][Full Text] [Related]
10. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
11. Spreading of P301S Aggregated Tau Investigated in Organotypic Mouse Brain Slice Cultures.
Korde DS; Humpel C
Biomolecules; 2022 Aug; 12(9):. PubMed ID: 36139003
[TBL] [Abstract][Full Text] [Related]
12. Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease.
Stozicka Z; Zilka N; Novak P; Kovacech B; Bugos O; Novak M
J Neuroinflammation; 2010 Oct; 7():64. PubMed ID: 20937161
[TBL] [Abstract][Full Text] [Related]
13. Regional vulnerability and spreading of hyperphosphorylated tau in seeded mouse brain.
Detrez JR; Maurin H; Van Kolen K; Willems R; Colombelli J; Lechat B; Roucourt B; Van Leuven F; Baatout S; Larsen P; Nuydens R; Timmermans JP; De Vos WH
Neurobiol Dis; 2019 Jul; 127():398-409. PubMed ID: 30878534
[TBL] [Abstract][Full Text] [Related]
14. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
15. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.
Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA
Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907
[TBL] [Abstract][Full Text] [Related]
16. Transgenic mice overexpressing amyloid beta protein are an incomplete model of Alzheimer disease.
Schwab C; Hosokawa M; McGeer PL
Exp Neurol; 2004 Jul; 188(1):52-64. PubMed ID: 15191802
[TBL] [Abstract][Full Text] [Related]
17. Synthetic tau fibrils mediate transmission of neurofibrillary tangles in a transgenic mouse model of Alzheimer's-like tauopathy.
Iba M; Guo JL; McBride JD; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2013 Jan; 33(3):1024-37. PubMed ID: 23325240
[TBL] [Abstract][Full Text] [Related]
18. Distribution of spleen tyrosine kinase and tau phosphorylated at tyrosine 18 in a mouse model of tauopathy and in the human hippocampus.
Köhler C; Fuhr V; Dinekov M
Brain Res; 2017 Dec; 1677():1-13. PubMed ID: 28919467
[TBL] [Abstract][Full Text] [Related]
19. Sensory Neurons from Tau Transgenic Mice and Their Utility in Drug Screening.
Tolkovsky AM; Brelstaff J
Methods Mol Biol; 2018; 1727():93-105. PubMed ID: 29222775
[TBL] [Abstract][Full Text] [Related]
20. α-Lipoic acid improves abnormal behavior by mitigation of oxidative stress, inflammation, ferroptosis, and tauopathy in P301S Tau transgenic mice.
Zhang YH; Wang DW; Xu SF; Zhang S; Fan YG; Yang YY; Guo SQ; Wang S; Guo T; Wang ZY; Guo C
Redox Biol; 2018 Apr; 14():535-548. PubMed ID: 29126071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
